News and Events

Topics

  • TOPCON selected for the fourth consecutive year as a Digital Transformation Stock (DX stock), and first time chosen for the DX Grand Prix!

    Topcon Corporation (Headquarters: Itabashi, Tokyo; President and CEO: Takashi Eto) has been selected for the DX Grand Prix 2023 in the Digital Transformation Stock (DX Stock) designated by the METI (Ministry of Economy, Trade, and Industry) and the Tokyo Stock Exchange.DX Stocks are selected for each industry category, targeting companies listed on the Tokyo Stock Exchange that have established internal systems to promote DX that contributes to improving corporate value. These companies fundamentally transform their business models based on digital technologies and aim to achieve new growth and enhance their competitiveness through digital transformation.Topcon has been selected for four consecutive years since 2020, and this year was chosen as a “DX Grand Prix company,” an award for being a leading company in the selected stocks.Topcon’s corporate identity is “Topcon contributes to enrich human life by solving the societal challenges within healthcare, agriculture, and infrastructure.” We have been creating new markets by providing DX solutions that transform conventional work processes through digitization, automation, and networking technologies in the global healthcare, agriculture, and infrastructure markets.■ Topcon’s DX Solutions for Solving Societal Challenges in Healthcare, Agriculture, and Infrastructure.[DX Grand Prix 2023 Evaluation Points]Topcon places DX as a driving force for business transformation, and the evaluation points are comprehensive and specific in terms of contributing to corporate value and realization capabilities. The corporate identity states that ” Topcon contributes to enrich human life by solving the societal challenges within healthcare, agriculture, and infrastructure.” and aims to solve these issues with DX solutions. The company actively engages in M&A and partnerships, incorporating advanced technologies and expanding services. They provide integrated solutions that combine technology and services, not just selling products or services, to address the challenges in the target industries. Expectations are high for future developments.Going forward, with a customer-oriented, field-oriented approach and a spirit of challenge, we will continue to strive for “the company that is needed” by stakeholders and promote ESG (environmental, social, and governance) management through our business

  • Topcon Announces eyeRISE 2021 Virtual Symposia & Expo

    Two-Day Special Event Will Showcase The Latest Innovations in Eye CareOAKLAND, NJ – January, 2021 – Topcon Healthcare, a leading provider of medical devices and software solutions for the global eye care community, announced today that it will host a two-day virtual symposia and expo entitled eyeRISE on February 9-10, 2021.eyeRISE, or Eye Research Innovation Symposia & Expo, is a new, multi-disciplinary virtual congress showcasing the latest innovations in eye care.  It will feature three solutions-focused tracks, delivering clinical and practical education through symposia, roundtable discussions and interactive workshops.The two-day special event will feature more than three dozen globally-renowned speakers representing 17 countries and a range of specialties.  Educational tracks are Building Clinical Confidence which includes topics focused on retina, glaucoma and imaging;  Entering New Markets which addresses the barriers to entering myopia and dry eye management; and Too Many Patients, Not Enough Time highlighting topics such as ocular telehealth and remote diagnostics.“eyeRISE will build on the success of our previous ISSOCT conferences and expand to include all facets of eye care, delivering clinical education for the retina, glaucoma and anterior segment subspecialties. The esteemed lecture panel will present their clinical findings on the latest research topics and innovation in eye care. It should prove to be a highly informative and enlightening meeting for all attendees,”Richard F. Spaide, MD, of Vitreous Retina Macula Consultants of New York, United StatesISSOCT Chairman“We are very excited to announce eyeRISE, a one-of-a-kind, ground-breaking event that will bring together some of the most recognized names in the eye care industry to discuss the latest research and trends in patient care and practice management.  In the absence of live meetings, eyeRISE provides an engaging, interactive virtual platform and offers education for a wide range of disciplines.  It features solution-focused tracks for real world clinical and business management applications.  eyeRISE is the culmination of Topcon’s unwavering commitment to support continued innovation in eye care,” stated Carolyn Evangelista, Global Director of Medical Affairs for Topcon Healthcare.“Having the opportunity to network with colleagues and learn about the latest trends and technologies in eye care is critical for today’s practitioners, particularly in light of the global pandemic. eyeRISE provides practitioners with a unique opportunity to interact with the faculty and each other and gain practical tips and clinical insights.  Given the challenges facing today’s eye care practitioners, eyeRISE represents a wonderful learning opportunity for all clinicians,” summarized faculty member Mingguang He, MD, PhD, Professor at the University of Melbourne, Australia.For more information on eyeRISE or to register for the event, please visit Eyerise2021.com.About Topcon HealthcareTopcon Healthcare sees eye health differently. Our vision is to empower providers with smart and efficient technologies for enhanced patient care. Keeping pace with the ever- changing landscape of the healthcare industry, we offer the latest integrated solutions including advanced multimodal imaging, vendor-neutral data management, safe distancing and ground-breaking remote diagnostic technology.A globally-oriented business, Topcon is focused on developing solutions towards solving societal challenges in the mega-domains of healthcare, agriculture, and infrastructure. In healthcare, these challenges include increasing eye disease, rising medical costs, access to healthcare and physician shortages. By investing in value-driven innovations, Topcon works to enable people to enjoy good health and a high quality of life.

  • Topcon Achieves #1 Market Position in OCT Devices

    Leads the OCT Market with Innovative Multimodal TechnologyOAKLAND, NJ – October 5, 2020 – Topcon Healthcare, a leading provider of medical devices and software solutions for the global eye care community, announced today that it has achieved the #1 position in the global OCT market, as reported by Market Scope’s 2020 Ophthalmic Diagnostic Equipment Market Report.Topcon leads the global market in the OCT segment with a 27.9 percent share.Its lineup of instruments includes the versatile Maestro2 Robotic OCT and the Triton Swept Source OCT. Both devices combine fundus and OCT functionality in an easy-to-use platform.“The Maestro2 and the Triton are engineered to help ECP’s answer complex clinical questions quickly, easily, and confidently. By delivering multiple images and data points with one click of a button in a format that is easy to understand and interpret, the Maestro2 and Triton meet the demands of today’s busy practitioners. We are thrilled at the way the market has embraced this technology,” stated Greg Hoffmeyer, Director of OCT Clinical Sales for Topcon Healthcare.The versatile Maestro2 combines fundus and OCT functionality in one device.“We are very pleased to have achieved the #1 market position in OCT devices. Our team has been hard at work leveraging the latest technology to develop versatile OCT devices that enhance practice workflow and provide exceptional clinical utility. The Market Scope recognition is confirmation that our devices are being well received by ECPs and are meeting their clinical needs.”About Topcon HealthcareTopcon Healthcare sees eye health differently. Our vision is to empower providers with smart and efficient technologies for enhanced patient care. Keeping pace with the ever- changing landscape of the healthcare industry, we offer the latest integrated solutions including advanced multimodal imaging, vendor-neutral data management, safe distancing and ground-breaking remote diagnostic technology.A globally-oriented business, Topcon is focused on developing solutions towards solving societal challenges in the mega-domains of healthcare, agriculture, and infrastructure. In healthcare, these challenges include increasing eye disease, rising medical costs, access to healthcare and physician shortages. By investing in value-driven innovations, Topcon works to enable people to enjoy good health and a high quality of life.

SEE MORE

News

  • Topcon Healthcare Announces Framelens Optical as Official Distributor in Brunei

    Topcon Healthcare is proud to announce the appointment of Framelens Optical as its official distributor in Brunei. This strategic partnership aims to enhance the availability and support of Topcon’s advanced products and services within the region.Framelens Optical, renowned for its dynamic approach and unwavering commitment to customer satisfaction in medical equipment distribution, emerges as an ideal partner for Topcon Healthcare. With a steadfast focus on delivering high-quality products and exceptional after sales service, making it an ideal partner for Topcon. This collaboration will focus on providing comprehensive solutions to eye care professionals, ensuring they have access to the latest technology and innovations in Topcon’s product lineup, thereby enhancing healthcare delivery.“We are excited to welcome Framelens Optical to the Topcon family,” said Leo Nagatake, Managing Director of Topcon Healthcare SEA. “Their expertise in efficient distribution and commitment to redefining standards of care align seamlessly with our values. We are confident that this partnership will greatly benefit our customers in Brunei”.As part of this collaboration, Framelens Optical will offer a comprehensive range of Topcon products, including the acclaimed Iridex series. In addition to product distribution, Framelens Optical will provide training and support to empower eye care professionals in Brunei to leverage the full potential of Topcon’s cutting-edge technology.   For more information about Topcon products and services in Brunei, please contact Framelens Optical at sales.framelens@gmail.com or visit https://www.spectaculargroup.my/framelens-optical.

  • Announcing Exclusive Partnership with Espansione Group

    Aimed at Driving Disruptive Innovation in Eye Care and Beyond in South-East AsiaTopcon Singapore Medical (referred to as “Topcon” in this document for brevity’s sake) and Espansione Group announce today a long-term exclusive partnership for the South-East Asia region.Starting April 1, 2023, Topcon will be the official and sole distributor for the South East Asian region of Espansione Group’s full portfolio, including light-based technologies such as Light Modulation® Low-level Light Therapy (LM® LLLT), its signature photobiomodulation technology, and Optimal Power Energy® Intense Pulsed Light (OPE® IPL).“We’re thrilled to grow our relationship with Topcon even stronger, including the South-East Asian region to our global collaboration efforts” commented Matteo Corbellino, Chief Marketing & Innovation Officer at Espansione Group. “We found a true partner in Topcon with a highly engaged and capable team striving to always deliver an extremely high level of service. We both want to raise the bar in the dry eye field and beyond, and that’s where we’ve found alignment. We believe that this partnership will create a powerful synergy that will enable us to push the boundaries of what’s possible in ophthalmology and beyond—as our technologies gain momentum worldwide, APAC and SEA in particular will be increasingly relevant for us.” “It's been Topcon Asia leadership's vision to look for ground-breaking type of collaborations. Our chance to meet the Espansione executive team gave us the opportunity to turn this vision into a reality” said Leo Nagatake, Managing Director at Topcon. “We see this strategic alliance with Espansione paving the way for our privileged access into their range of highly innovative and forward-thinking treatment products and solutions complementing the comprehensive range of Topcon's diagnostic equipment such as our MYAH - the unique multifunctional instrument for the management of dry eye & myopia. This synergistic partnership will further expand our service spectrum enabling us to provide more wholistic solutions to our esteemed clientele; from pre-diagnosis towards effective dry eye treatment followed by post treatment follow ups that will eventually benefit our end patients with a comprehensive end to end experience.”Professionals are encouraged to contact Topcon to obtain details on the portfolio of solutions in light therapy and digital imaging showcased with this partnership, including eye-light® , meibomask®, my-mask® and me-check®.About Espansione GroupEspansione Group is an established player in the medtech industry. Since 1981, Espansione Group has delivered the highest standard in the industry. Every day, the company invests heavily in researching and developing the Espansione Ecosystem to achieve its ambition: establishing new paradigms in ophthalmology and beyond, driven by its desire to provide its partners and their patients with the best, certified medical technologies, Light Modulation® Low-level Light Therapy (LM® LLLT) and Optimal Power Energy® Intense Pulsed Light (OPE® IPL). Present in over 50 countries, Espansione Group's aims to continue its strong growth in years to come, relentlessly focusing its efforts on research, development, and customer excellence.   For more information, see www.espansionegroup.itAbout Topcon HealthcareTopcon Healthcare sees eye health differently. Our vision is to empower providers with smart and efficient technologies for enhanced patient care. Keeping pace with the ever-changing landscape of the healthcare industry, we offer the latest integrated solutions including advanced multi-modal imaging, vendor-neutral data management, safe distancing, and ground- breaking remote diagnostic technology.A globally-oriented business, Topcon is focused on developing solutions towards solving societal challenges in the mega-domains of healthcare, agriculture, and infrastructure. In healthcare, these challenges include increasing eye disease, rising medical costs, access to healthcare and physician shortages. By investing in value-driven innovations, Topcon works to enable people to enjoy good health and a high quality of life.For more information, see https://topconhealthcare.sgMedia ContactsEspansione GroupMatteo Corbellinomatteo.corbellino@espansione.itTopcon Singapore MedicalPatrick Foopfoo@topcon.com

  • Notice of Changes of President and CEO (Replacement of President)

    January 30, 2023Topcon Corporation (TSE: 7732) hereby announces that the change of President and CEO was resolved at a meeting of the board of directors held today. The appointments will take effect on April 1, 2023.Change of President and CEO(effective April 1, 2023)NameNew PositionCurrent PositionSatoshi HiranoRepresentative Director,ChairmanRepresentative Director,President & CEOTakashi EtoRepresentative Director,President & CEORepresentative Director,Executive Vice PresidentGeneral Manager, Quality Assurance Div.Takashi EtoTopcon Corporation, the parent company of all Topcon Healthcare companies, announced changes in their president and CEO position that will be effective with the new fiscal year. Takashi Eto will assume the position of Representative Director,  President and CEO, effective April 1, 2023. Current Topcon Corporation President and CEO Satoshi Hirano has served in the role since 2013 and will continue to contribute to the development of Topcon as Chairman of the Board, assisting and advising the new president.Read the news on the Topcon Corporation Website : link

SEE MORE

Events

  • TODAY
  • EVENT